5 July 2022
-
45 Minutes
MRD - What will change in the next year?
Multiple Myeloma~myelomaconnect~NDMM~RRMM
EM-93560
22 June 2022
-
64 Minutes
Highlights from EHA 2022: Expert insights and clinical implications for the management of patients with multiple myeloma
EHA2022~Multiple Myeloma~NDMM~RRMM
EM-93557
21 June 2022
-
63 Minutes
Challenges in CLL: how does the data from EHA 2022 inform key management questions?
challengesincll~CLL~EHA2022
EM-78442
20 June 2022
-
1 Hours
Challenges in NHL: how does the data from EHA 2022 inform key management questions?
challengesinnhl~EHA2022~NHL
EM-78670
31 May 2022
-
51 Minutes
Challenges in NHL: managing WM-associated complications: a case study-based discussion
challengesinnhl~NHL
EM-78665
19 May 2022
-
47 Minutes
Bispecific antibodies: raising new horizons for RRMM?
myelomaconnect~RRMM
EM-88730
17 May 2022
-
46 Minutes
Challenges in CLL: What does the future hold - are we approaching cure in CLL?
challengesincll~CLL
EM-78439
12 May 2022
-
48 Minutes
Practical considerations around CAR T-cell therapies for patients with multiple myeloma
MM~Multiple Myeloma~myelomaconnect~RRMM
EM-78417
10 May 2022
-
46 Minutes
Bridging the gap between patient and clinician perspectives in myeloma care
MM~Multiple Myeloma~myelomaconnect~NDMM~RRMM
EM-78406
5 May 2022
-
46 Minutes
Challenges in CLL: Where are we with MRD assessment?
challengesincll~CLL
EM-78437